Twelve‐Month results from multicenter, open‐label, randomized controlled clinical trial comparing differential target multiplexed spinal cord stimulation and traditional spinal cord stimulation in subjects with chronic intractable back pain and leg pain

Background: Spinal cord stimulation (SCS) is a well‐established treatment for chronic intractable pain of the trunk and/or limbs; however, low back pain (LBP) is difficult to treat using traditional SCS. Differential Target Multiplexed spinal cord stimulation (DTM SCS) is an advanced approach inspir...

Descripción completa

Detalles Bibliográficos
Publicado en:Pain Practice Vol. 21; no. 8; pp. 912 - 924
Autores principales: Fishman, Michael, Cordner, Harold, Justiz, Rafael, Provenzano, David, Merrell, Christopher, Shah, Binit, Naranjo, Julian, Kim, Philip, Calodney, Aaron, Carlson, Jonathan, Bundschu, Richard, Sanapati, Mahendra, Mangal, Vipul, Vallejo, Ricardo
Formato: research tables/charts randomized controlled trial Journal Article
Publicado: Wiley-Blackwell Nov2021
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=153458210&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 153458210
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        15307085
        HYN
      jtl: Pain Practice
      issn: 15307085
      maglogo: Y
    pubinfo:
      dt: Nov2021
      vid: 21
      iid: 8
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        153458210
        152084216
        153458210
        153458210
        10.1111/papr.13066
        153458210
      ppf: 912
      ppct: 12
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Twelve‐Month results from multicenter, open‐label, randomized controlled clinical trial comparing differential target multiplexed spinal cord stimulation and traditional spinal cord stimulation in subjects with chronic intractable back pain and leg pain
      aug:
        au:
          Fishman, Michael
          Cordner, Harold
          Justiz, Rafael
          Provenzano, David
          Merrell, Christopher
          Shah, Binit
          Naranjo, Julian
          Kim, Philip
          Calodney, Aaron
          Carlson, Jonathan
          Bundschu, Richard
          Sanapati, Mahendra
          Mangal, Vipul
          Vallejo, Ricardo
        affil: Center for Interventional Pain and Spine, Exton Pennsylvania,, USA
      sug:
        subj:
          Leg Physiopathology
          Chronic Pain Therapy
          Back Pain Therapy
          Spinal Cord Stimulation Methods
          Treatment Outcomes Evaluation
          Human
          Randomized Controlled Trials
          Multicenter Studies
          Comparative Studies
          Time Factors
          Prospective Studies
          Chronic Pain Symptoms
          Pain Measurement
          Health Status
          Activities of Daily Living
          Patient Satisfaction
          Patient Safety
          Descriptive Statistics
      ab: Background: Spinal cord stimulation (SCS) is a well‐established treatment for chronic intractable pain of the trunk and/or limbs; however, low back pain (LBP) is difficult to treat using traditional SCS. Differential Target Multiplexed spinal cord stimulation (DTM SCS) is an advanced approach inspired from animal studies demonstrating improved pain‐related behavior and pain‐relevant biological processes. Objective: The purpose of this study was to compare the effectiveness of DTM SCS and traditional SCS in treating chronic LBP and leg pain (LP). Methods: This prospective, postmarket randomized controlled trial compared DTM SCS to traditional SCS in patients with chronic LBP and LP. Primary end point was LBP responder rate (percentage of subjects with ≥ 50% relief) at 3 months. Noninferiority and superiority were assessed. Other outcomes included mean change in back and leg pain, responder rates, disability, global health, satisfaction, and safety profile throughout the 12‐month follow‐up. Results: One hundred twenty‐eight subjects were randomized across 12 centers (67 DTM SCS and 61 traditional SCS). Of the 94 patients implanted, 46 subjects in each group completed the 3‐month assessment. LBP responder rate of 80.1% with DTM SCS was superior to 51.2% with traditional SCS (p = 0.0010). Mean LBP reduction (5.36 cm) with DTM SCS was greater than reduction (3.37 cm) with traditional SCS (p < 0.0001). These results were sustained at 6 months and 12 months. Safety profiles were similar between treatment groups. Conclusion: Superiority of DTM SCS compared with traditional SCS for chronic LBP was demonstrated. Clinical improvements provided by DTM SCS were sustained over 12 months and are expected to significantly impact the management of chronic LBP.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        randomized controlled trial
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N